CTRI/2020/11/029311已完成3 期
Evaluation of clinical efficacy and safety of Acalypha indica impregnated thin film on radiation induced dermatitis
I0 个研究点目标入组 110 人开始时间: 待定最近更新:
试验速览
- 阶段
- 3 期
- 状态
- 已完成
- 发起方
- 入组人数
- 110
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
入选标准
- •1.Patient willing to give written informed consent form
- •2. Newly diagnosed with non metastatic breast cancer and undergoing adjuvant radiation for breast cancer who develop grade III radiation therapy induced moist desquamation
排除标准
- •1.Patient unwilling to take part in study
- •2.Patients with contraindications for Radiation therapy
- •3.Patients with radiation skin reactions of severity less than Grade III
- •4.Patients with pre existing skin conditions such as psoriasis, eczema, or connective tissue disorders or history of allergy to components used in trial dressings
- •5.Patients on steroids or immunosuppressant therapy
研究者
相似试验
招募中
2 期
Evaluation of Green Propolis as a oral Anti-inflammatory DrugHealthy volunteersSP5.001.047.138RBR-9zmfs9Faculdade de Medicina de Ribeirão Preto - FMRP
已完成
2 期
Clinical Study on AyuAsmo Capsules in AsthmaCTRI/2018/04/012980Welex Laboratories Pvt Ltd
已完成
不适用
A clinical study on the safety and efficacy of accelerated partial breast irradiation in breast-conserving therapyBreast cancerJPRN-UMIN000006474Department of Radiation Oncology and Image-applied Therapy, Graduate School of Medicine, Kyoto University50
尚未招募
1 期
Clinical efficacy and mechanism observation of acupuncture in improving skeletal muscle consumption in advanced lung cancer cachexiaCancer CachexiaITMCTR1900002392Chongqing Jiulongpo District Hospital of Traditional Chinese Medicine
进行中（未招募）
1 期
Clinical Study ProtocolSafety and efficacy of escalating doses of LEO 43204 applied once daily for two consecutive days on full balding scalp in subjects with actinic keratosis(sun spots)Part 1: A phase 1. Dose finding study. Follow-up period: 2-weeks Part 2: A phase 2, randomised, doubled, vehicle-controlled study. Follow up period: 8-weeksMedDRA version: 17.0Level: PTClassification code 10000614Term: Actinic keratosisSystem Organ Class: 10040785 - Skin and subcutaneous tissue disordersActinic KeratosisEUCTR2014-000037-23-DEEO Pharma A/S220